| |
| |
|
| Insider
Information: |
Latham John A |
| Relationship: |
Chief Scientific Officer |
| City: |
Bothell |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
244,180 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,610,118 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
244,180 |
|
|
| Total
Value |
$4,610,118 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alder Biopharmaceuticals Inc |
ALDR |
Chief Scientific Officer |
2018-11-30 |
244,180 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
68 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific OfficerOffice |
• – – |
2014-05-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
208,484 |
|
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2017-05-31 |
4 |
A |
$13.09 |
$4,359 |
D/D |
333 |
242,736 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2017-11-30 |
4 |
A |
$9.35 |
$4,413 |
D/D |
472 |
243,208 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2018-11-30 |
4 |
A |
$9.35 |
$4,553 |
D/D |
487 |
244,180 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2016-07-26 |
4 |
OE |
$1.65 |
$1,341 |
D/D |
813 |
243,013 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2016-07-26 |
4 |
AS |
$30.00 |
$24,392 |
D/D |
(813) |
242,200 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2016-08-01 |
4 |
S |
$31.75 |
$113,484 |
D/D |
(3,574) |
242,232 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2016-12-01 |
4 |
OE |
$1.65 |
$5,999 |
D/D |
3,636 |
246,039 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2016-12-01 |
4 |
AS |
$22.64 |
$82,812 |
D/D |
(3,636) |
242,403 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2015-03-02 |
4 |
OE |
$0.39 |
$1,750 |
D/D |
4,545 |
213,533 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2015-03-02 |
4 |
AS |
$26.26 |
$119,340 |
D/D |
(4,545) |
208,988 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2015-04-01 |
4 |
OE |
$0.39 |
$1,750 |
D/D |
4,545 |
213,533 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2015-04-01 |
4 |
AS |
$27.42 |
$124,609 |
D/D |
(4,545) |
208,988 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2015-05-01 |
4 |
AS |
$25.67 |
$116,663 |
D/D |
(4,545) |
208,988 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2015-05-01 |
4 |
OE |
$0.39 |
$1,750 |
D/D |
4,545 |
213,533 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2015-06-01 |
4 |
OE |
$0.39 |
$1,750 |
D/D |
4,545 |
213,992 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2015-06-01 |
4 |
AS |
$41.53 |
$188,757 |
D/D |
(4,545) |
209,447 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2015-07-01 |
4 |
OE |
$0.39 |
$1,750 |
D/D |
4,545 |
213,992 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2015-07-01 |
4 |
AS |
$51.13 |
$232,381 |
D/D |
(4,545) |
209,447 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2015-08-03 |
4 |
OE |
$0.39 |
$1,750 |
D/D |
4,545 |
213,992 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2015-08-03 |
4 |
AS |
$45.62 |
$207,322 |
D/D |
(4,545) |
209,447 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2015-09-01 |
4 |
AS |
$38.41 |
$175,059 |
D/D |
(4,545) |
209,447 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2015-09-01 |
4 |
OE |
$0.39 |
$1,750 |
D/D |
4,545 |
213,992 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2015-10-01 |
4 |
OE |
$0.39 |
$1,750 |
D/D |
4,545 |
245,810 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
Chief Scientific Officer |
• – – |
2015-10-01 |
4 |
AS |
$32.22 |
$146,603 |
D/D |
(4,545) |
241,265 |
0 |
- |
|
68 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
